EPIRUS Biopharmaceuticals, Inc.: key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2015)
- -$52.2M
- Total Assets (FY2015)
- $72.3M
- Total Equity (FY2015)
- $36.4M
- Cash Flows from Operating Activities (FY2015)
- -$46.6M
Source: EPIRUS Biopharmaceuticals, Inc. 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
